These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12767596)

  • 1. Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues.
    Lee S; Yi KY; Kim SK; Suh J; Kim NJ; Yoo SE; Lee BH; Seo HW; Kim SO; Lim H
    Eur J Med Chem; 2003 May; 38(5):459-71. PubMed ID: 12767596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
    Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS
    J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anti-ischemic ATP-sensitive potassium channel (K(ATP)) opener without vasorelaxation: N-(6-aminobenzopyranyl)-N'-benzyl-N' '-cyanoguanidine analogue.
    Yoo SE; Yi KY; Lee S; Suh J; Kim N; Lee BH; Seo HW; Kim SO; Lee DH; Lim H; Shin HS
    J Med Chem; 2001 Nov; 44(24):4207-15. PubMed ID: 11708922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
    Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties.
    Breschi MC; Calderone V; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
    J Med Chem; 2006 Dec; 49(26):7600-2. PubMed ID: 17181142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia.
    Grover GJ; Atwal KS
    Cardiovasc Drug Rev; 2002; 20(2):121-36. PubMed ID: 12177690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic preconditioning and a mitochondrial KATP channel opener both produce cardioprotection accompanied by F1F0-ATPase inhibition in early ischaemia.
    Ala-Rämi A; Ylitalo KV; Hassinen IE
    Basic Res Cardiol; 2003 Jul; 98(4):250-8. PubMed ID: 12835954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria.
    Brustovetsky T; Shalbuyeva N; Brustovetsky N
    J Physiol; 2005 Oct; 568(Pt 1):47-59. PubMed ID: 16051627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.
    Rovnyak GC; Ahmed SZ; Ding CZ; Dzwonczyk S; Ferrara FN; Humphreys WG; Grover GJ; Santafianos D; Atwal KS; Baird AJ; McLaughlin LG; Normandin DE; Sleph PG; Traeger SC
    J Med Chem; 1997 Jan; 40(1):24-34. PubMed ID: 9016325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
    Atwal KS; Grover GJ; Ahmed SZ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1995 Aug; 38(17):3236-45. PubMed ID: 7650676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
    Atwal KS; Grover GJ; Ahmed SZ; Ferrara FN; Harper TW; Kim KS; Sleph PG; Dzwonczyk S; Russell AD; Moreland S
    J Med Chem; 1993 Nov; 36(24):3971-4. PubMed ID: 8254626
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats.
    Neckár J; Szárszoi O; Koten L; Papousek F; Ost'ádal B; Grover GJ; Kolár F
    Cardiovasc Res; 2002 Aug; 55(3):567-75. PubMed ID: 12160954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
    Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
    Atwal KS; Wang P; Rogers WL; Sleph P; Monshizadegan H; Ferrara FN; Traeger S; Green DW; Grover GJ
    J Med Chem; 2004 Feb; 47(5):1081-4. PubMed ID: 14971888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.